nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrahydrobiopterin—TH—sympathetic nervous system—dilated cardiomyopathy	0.127	0.384	CbGeAlD
Tetrahydrobiopterin—NOS3—pulmonary artery—dilated cardiomyopathy	0.118	0.355	CbGeAlD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—MAS1—dilated cardiomyopathy	0.0383	0.0786	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—NR3C2—dilated cardiomyopathy	0.0298	0.0612	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—cardiac ventricle—dilated cardiomyopathy	0.0245	0.0739	CbGeAlD
Tetrahydrobiopterin—NOS3—myocardium—dilated cardiomyopathy	0.023	0.0695	CbGeAlD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0197	0.0405	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0183	0.0376	CbGpPWpGaD
Tetrahydrobiopterin—TH—heart—dilated cardiomyopathy	0.0179	0.0539	CbGeAlD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—AGTR2—dilated cardiomyopathy	0.0161	0.033	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—heart—dilated cardiomyopathy	0.0161	0.0485	CbGeAlD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—ACE—dilated cardiomyopathy	0.0137	0.0282	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0134	0.0275	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0131	0.0268	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—AGTR1—dilated cardiomyopathy	0.0124	0.0254	CbGpPWpGaD
Tetrahydrobiopterin—TH—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0113	0.0233	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0105	0.0216	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00955	0.0196	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—dilated cardiomyopathy	0.00934	0.0192	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—ACE Inhibitor Pathway—AGT—dilated cardiomyopathy	0.00871	0.0179	CbGpPWpGaD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—NPPA—dilated cardiomyopathy	0.0087	0.0179	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—ADRB1—dilated cardiomyopathy	0.00852	0.0175	CbGpPWpGaD
Tetrahydrobiopterin—Gastritis—Spironolactone—dilated cardiomyopathy	0.00831	0.0458	CcSEcCtD
Tetrahydrobiopterin—TH—Monoamine Transport—AGT—dilated cardiomyopathy	0.00757	0.0155	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0075	0.0154	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—VCL—dilated cardiomyopathy	0.00745	0.0153	CbGpPWpGaD
Tetrahydrobiopterin—TH—p38 signaling mediated by MAPKAP kinases—RAF1—dilated cardiomyopathy	0.00736	0.0151	CbGpPWpGaD
Tetrahydrobiopterin—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00652	0.0359	CcSEcCtD
Tetrahydrobiopterin—NOS3—Validated transcriptional targets of AP1 family members Fra1 and Fra2—GJA1—dilated cardiomyopathy	0.00642	0.0132	CbGpPWpGaD
Tetrahydrobiopterin—Urine output increased—Furosemide—dilated cardiomyopathy	0.00636	0.0351	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFR2 mediated vascular permeability—RAC1—dilated cardiomyopathy	0.00611	0.0125	CbGpPWpGaD
Tetrahydrobiopterin—Polyuria—Furosemide—dilated cardiomyopathy	0.00582	0.0321	CcSEcCtD
Tetrahydrobiopterin—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.0058	0.032	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—GJA1—dilated cardiomyopathy	0.00556	0.0114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—ACTC1—dilated cardiomyopathy	0.00556	0.0114	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—RYR2—dilated cardiomyopathy	0.00523	0.0107	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—AGTR1—dilated cardiomyopathy	0.00522	0.0107	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.0051	0.0105	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—heart—dilated cardiomyopathy	0.0051	0.0154	CbGeAlD
Tetrahydrobiopterin—Irritability—Furosemide—dilated cardiomyopathy	0.00487	0.0269	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—IL10—dilated cardiomyopathy	0.00482	0.0099	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—ITGB1—dilated cardiomyopathy	0.00478	0.00982	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00461	0.0254	CcSEcCtD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00442	0.00908	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—RPS6KB1—dilated cardiomyopathy	0.00425	0.00873	CbGpPWpGaD
Tetrahydrobiopterin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00421	0.0232	CcSEcCtD
Tetrahydrobiopterin—TH—AP-1 transcription factor network—AGT—dilated cardiomyopathy	0.00405	0.00831	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00398	0.022	CcSEcCtD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—RAC1—dilated cardiomyopathy	0.00384	0.00789	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00373	0.00765	CbGpPWpGaD
Tetrahydrobiopterin—Irritability—Lisinopril—dilated cardiomyopathy	0.00366	0.0202	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00365	0.0201	CcSEcCtD
Tetrahydrobiopterin—NOS3—Endothelin Pathways—RAF1—dilated cardiomyopathy	0.00355	0.0073	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—RAC1—dilated cardiomyopathy	0.00351	0.00721	CbGpPWpGaD
Tetrahydrobiopterin—TH—Monoamine Transport—TNF—dilated cardiomyopathy	0.00343	0.00705	CbGpPWpGaD
Tetrahydrobiopterin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00343	0.0189	CcSEcCtD
Tetrahydrobiopterin—PTGS2—S1P1 pathway—RAC1—dilated cardiomyopathy	0.00341	0.007	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0034	0.0187	CcSEcCtD
Tetrahydrobiopterin—Gastritis—Lisinopril—dilated cardiomyopathy	0.00339	0.0187	CcSEcCtD
Tetrahydrobiopterin—TPH1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00324	0.00664	CbGpPWpGaD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00323	0.00664	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00316	0.0174	CcSEcCtD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—GJA1—dilated cardiomyopathy	0.0031	0.00636	CbGpPWpGaD
Tetrahydrobiopterin—Neutropenia—Lisinopril—dilated cardiomyopathy	0.0031	0.0171	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—RAC1—dilated cardiomyopathy	0.00308	0.00632	CbGpPWpGaD
Tetrahydrobiopterin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00308	0.017	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00308	0.00631	CbGpPWpGaD
Tetrahydrobiopterin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00308	0.017	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00305	0.0168	CcSEcCtD
Tetrahydrobiopterin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00293	0.0162	CcSEcCtD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00293	0.00601	CbGpPWpGaD
Tetrahydrobiopterin—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00291	0.0161	CcSEcCtD
Tetrahydrobiopterin—Rash—Spironolactone—dilated cardiomyopathy	0.00291	0.016	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00291	0.016	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—ANKRD1—dilated cardiomyopathy	0.0029	0.00595	CbGpPWpGaD
Tetrahydrobiopterin—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00289	0.016	CcSEcCtD
Tetrahydrobiopterin—Headache—Spironolactone—dilated cardiomyopathy	0.00289	0.0159	CcSEcCtD
Tetrahydrobiopterin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00287	0.0158	CcSEcCtD
Tetrahydrobiopterin—Agitation—Furosemide—dilated cardiomyopathy	0.00283	0.0156	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—RAC1—dilated cardiomyopathy	0.00278	0.00571	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Spironolactone—dilated cardiomyopathy	0.00274	0.0151	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—TAZ—dilated cardiomyopathy	0.00273	0.0056	CbGpPWpGaD
Tetrahydrobiopterin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00263	0.0145	CcSEcCtD
Tetrahydrobiopterin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00261	0.0144	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.0026	0.0143	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Calcium signaling in the CD4+ TCR pathway—FASLG—dilated cardiomyopathy	0.00257	0.00528	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00254	0.00521	CbGpPWpGaD
Tetrahydrobiopterin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00251	0.0138	CcSEcCtD
Tetrahydrobiopterin—TPH1—Metabolism—SDHA—dilated cardiomyopathy	0.00246	0.00506	CbGpPWpGaD
Tetrahydrobiopterin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00246	0.0136	CcSEcCtD
Tetrahydrobiopterin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00244	0.0134	CcSEcCtD
Tetrahydrobiopterin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00239	0.0132	CcSEcCtD
Tetrahydrobiopterin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00231	0.0127	CcSEcCtD
Tetrahydrobiopterin—NOS3—SHP2 signaling—RAF1—dilated cardiomyopathy	0.00226	0.00465	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00217	0.0119	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—ANKRD1—dilated cardiomyopathy	0.00212	0.00435	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.00209	0.00429	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00205	0.0113	CcSEcCtD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.00204	0.00419	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Myometrial Relaxation and Contraction Pathways—GJA1—dilated cardiomyopathy	0.00204	0.00419	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—TTN—dilated cardiomyopathy	0.00203	0.00416	CbGpPWpGaD
Tetrahydrobiopterin—Cough—Lisinopril—dilated cardiomyopathy	0.00201	0.0111	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling events mediated by VEGFR1 and VEGFR2—RAF1—dilated cardiomyopathy	0.00199	0.00409	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—TAZ—dilated cardiomyopathy	0.00199	0.00409	CbGpPWpGaD
Tetrahydrobiopterin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00198	0.0109	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00198	0.0109	CcSEcCtD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.00197	0.00405	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—GJA1—dilated cardiomyopathy	0.00197	0.00404	CbGpPWpGaD
Tetrahydrobiopterin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00196	0.0108	CcSEcCtD
Tetrahydrobiopterin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00195	0.0108	CcSEcCtD
Tetrahydrobiopterin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00188	0.0104	CcSEcCtD
Tetrahydrobiopterin—Infection—Lisinopril—dilated cardiomyopathy	0.00187	0.0103	CcSEcCtD
Tetrahydrobiopterin—TH—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00186	0.00382	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00185	0.0102	CcSEcCtD
Tetrahydrobiopterin—NOS3—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.00184	0.00378	CbGpPWpGaD
Tetrahydrobiopterin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00183	0.0101	CcSEcCtD
Tetrahydrobiopterin—PAH—Metabolism—SDHA—dilated cardiomyopathy	0.0018	0.0037	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.00178	0.00366	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	0.00176	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—ACTN2—dilated cardiomyopathy	0.00176	0.00361	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00172	0.00947	CcSEcCtD
Tetrahydrobiopterin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00172	0.00946	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00171	0.00352	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00168	0.00345	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—ANKRD1—dilated cardiomyopathy	0.00167	0.00342	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.00166	0.00342	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—dilated cardiomyopathy	0.00166	0.00341	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—RPS6KB1—dilated cardiomyopathy	0.00166	0.00341	CbGpPWpGaD
Tetrahydrobiopterin—Dizziness—Furosemide—dilated cardiomyopathy	0.00166	0.00915	CcSEcCtD
Tetrahydrobiopterin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00166	0.00914	CcSEcCtD
Tetrahydrobiopterin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00163	0.00897	CcSEcCtD
Tetrahydrobiopterin—NOS3—Thromboxane A2 receptor signaling—EGFR—dilated cardiomyopathy	0.0016	0.00328	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Furosemide—dilated cardiomyopathy	0.0016	0.0088	CcSEcCtD
Tetrahydrobiopterin—Rash—Furosemide—dilated cardiomyopathy	0.00158	0.00873	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00158	0.00872	CcSEcCtD
Tetrahydrobiopterin—Headache—Furosemide—dilated cardiomyopathy	0.00157	0.00867	CcSEcCtD
Tetrahydrobiopterin—TH—Metabolism—TAZ—dilated cardiomyopathy	0.00157	0.00321	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.00156	0.00321	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—SHP2 signaling—EGFR—dilated cardiomyopathy	0.00155	0.00319	CbGpPWpGaD
Tetrahydrobiopterin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00154	0.00849	CcSEcCtD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—RAC1—dilated cardiomyopathy	0.0015	0.00308	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—VCL—dilated cardiomyopathy	0.0015	0.00307	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Furosemide—dilated cardiomyopathy	0.00149	0.00822	CcSEcCtD
Tetrahydrobiopterin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00149	0.00821	CcSEcCtD
Tetrahydrobiopterin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00149	0.00821	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Overview of nanoparticle effects—TNF—dilated cardiomyopathy	0.00148	0.00303	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—SDHA—dilated cardiomyopathy	0.00142	0.00291	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.0014	0.00287	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.0014	0.00287	CbGpPWpGaD
Tetrahydrobiopterin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00139	0.00765	CcSEcCtD
Tetrahydrobiopterin—NOS3—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.00139	0.00285	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.00131	0.00269	CbGpPWpGaD
Tetrahydrobiopterin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00129	0.0071	CcSEcCtD
Tetrahydrobiopterin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00125	0.00687	CcSEcCtD
Tetrahydrobiopterin—PAH—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00123	0.00253	CbGpPWpGaD
Tetrahydrobiopterin—Vomiting—Lisinopril—dilated cardiomyopathy	0.0012	0.0066	CcSEcCtD
Tetrahydrobiopterin—Rash—Lisinopril—dilated cardiomyopathy	0.00119	0.00655	CcSEcCtD
Tetrahydrobiopterin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00119	0.00654	CcSEcCtD
Tetrahydrobiopterin—Headache—Lisinopril—dilated cardiomyopathy	0.00118	0.00651	CcSEcCtD
Tetrahydrobiopterin—NOS3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00115	0.00237	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00114	0.00235	CbGpPWpGaD
Tetrahydrobiopterin—Nausea—Lisinopril—dilated cardiomyopathy	0.00112	0.00617	CcSEcCtD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.00111	0.00229	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—NPPA—dilated cardiomyopathy	0.0011	0.00226	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00109	0.00224	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—TAZ—dilated cardiomyopathy	0.00109	0.00223	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—PSEN2—dilated cardiomyopathy	0.00107	0.00219	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00106	0.00218	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00104	0.00213	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000996	0.00205	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000995	0.00204	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—SDHA—dilated cardiomyopathy	0.000981	0.00201	CbGpPWpGaD
Tetrahydrobiopterin—TH—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000966	0.00198	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000791	0.00162	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000764	0.00157	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—ITGB1—dilated cardiomyopathy	0.000751	0.00154	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000728	0.00149	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—EGF/EGFR Signaling Pathway—EGFR—dilated cardiomyopathy	0.000682	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—dilated cardiomyopathy	0.000681	0.0014	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—GPX1—dilated cardiomyopathy	0.00067	0.00137	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—CD36—dilated cardiomyopathy	0.000652	0.00134	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—CD36—dilated cardiomyopathy	0.00064	0.00131	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—RAC1—dilated cardiomyopathy	0.000603	0.00124	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—NPPA—dilated cardiomyopathy	0.0006	0.00123	CbGpPWpGaD
Tetrahydrobiopterin—TPH1—Metabolism—AGT—dilated cardiomyopathy	0.000587	0.00121	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—PSEN2—dilated cardiomyopathy	0.000581	0.00119	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000569	0.00117	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000549	0.00113	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000538	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—RAC1—dilated cardiomyopathy	0.000537	0.0011	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—GPX1—dilated cardiomyopathy	0.00049	0.00101	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—CD36—dilated cardiomyopathy	0.000477	0.000979	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000472	0.000969	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—TAZ—dilated cardiomyopathy	0.000444	0.000911	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000433	0.000889	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Metabolism—AGT—dilated cardiomyopathy	0.000429	0.000881	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000407	0.000835	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—SDHA—dilated cardiomyopathy	0.000401	0.000824	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Hemostasis—RAF1—dilated cardiomyopathy	0.0004	0.000821	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—GPX1—dilated cardiomyopathy	0.000385	0.00079	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—CD36—dilated cardiomyopathy	0.000375	0.000769	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000361	0.000742	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000361	0.000742	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.00036	0.000738	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000357	0.000732	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—RAF1—dilated cardiomyopathy	0.000356	0.00073	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.000342	0.000703	CbGpPWpGaD
Tetrahydrobiopterin—TH—Metabolism—AGT—dilated cardiomyopathy	0.000337	0.000692	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000336	0.000689	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000325	0.000668	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RAC1—dilated cardiomyopathy	0.000292	0.0006	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000278	0.00057	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—GPX1—dilated cardiomyopathy	0.000267	0.000547	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000264	0.000541	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—CD36—dilated cardiomyopathy	0.00026	0.000533	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—NPPA—dilated cardiomyopathy	0.000245	0.000504	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000245	0.000503	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000245	0.000502	CbGpPWpGaD
Tetrahydrobiopterin—PAH—Disease—EGFR—dilated cardiomyopathy	0.000244	0.000501	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000238	0.000489	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—PSEN2—dilated cardiomyopathy	0.000238	0.000488	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Metabolism—AGT—dilated cardiomyopathy	0.000234	0.00048	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000233	0.000478	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000226	0.000465	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000215	0.000441	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000205	0.00042	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000195	0.000401	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—RAF1—dilated cardiomyopathy	0.000194	0.000398	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000136	0.000278	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Disease—EGFR—dilated cardiomyopathy	0.000133	0.000273	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RAC1—dilated cardiomyopathy	0.000119	0.000245	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—GPX1—dilated cardiomyopathy	0.000109	0.000224	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—CD36—dilated cardiomyopathy	0.000106	0.000218	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Metabolism—AGT—dilated cardiomyopathy	9.56e-05	0.000196	CbGpPWpGaD
Tetrahydrobiopterin—NOS3—Signaling Pathways—EGFR—dilated cardiomyopathy	9.3e-05	0.000191	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—RAF1—dilated cardiomyopathy	7.92e-05	0.000163	CbGpPWpGaD
Tetrahydrobiopterin—PTGS2—Disease—EGFR—dilated cardiomyopathy	5.43e-05	0.000112	CbGpPWpGaD
